Breaking News

Summit Therapeutics and Intel Lead Monday Afternoon’s Market Cap Stock Movements

Monday’s market has experienced significant activity, particularly among mega-cap and large-cap stocks. Investors are observing noteworthy movements, with Summit Therapeutics PLC experiencing a sharp decline, while Intel Corp sees upward momentum due to acquisition speculation. Here’s an overview of the most significant stock movers at the week’s outset.

Mega-Cap Movers (Market Cap $200B+)

  • There were no reported mega-cap companies with notable stock movements today.

Large-Cap Stock Movers (Market Cap $10B-$200B)

  • Summit Therapeutics PLC: -10.91%
  • Ke Holdings Inc: +7.2%
  • Sea Limited: Price target increased by BofA; +5.51%
  • Tencent Music Entertainment Group: +4.72%
  • Albemarle: +3.78%
  • New Oriental Education & Tech: -4.02%
  • JD.Com Inc ADR: +4.15%
  • Qualcomm’s rumored acquisition of Intel described as "almost too silly to comment on" by Citi; Intel Corp: +4.28%
  • Vistra Energy Corp: Price target raised at Morgan Stanley; +3.81%
  • Regeneron Pharmaceuticals: -3.43%

Mid-Cap Stock Movers (Market Cap $2B-$10B)

  • Miniso Group Holding Ltd: -17.35%; MINISO to become the largest shareholder of Yonghui Superstores
  • Biohaven Pharmaceutical Holding Co: +15.55%
  • AeroVironment: +11.4% as Troriluzole shows promise in slowing progression of SCA
  • ZIM Integrated Shipping Services: +10.32%
  • Geron Corp: -8.81%
  • TSLL: +8.86%
  • Edgewise Therapeutics: -7.18%
  • DigitalOcean Holdings: -6.87%

Small-Cap Stock Movers (Market Cap $300M-$2B)

  • Jin Medical International: -27.45%
  • NANO Nuclear Energy: +11.06%, targeting space with a new subsidiary
  • Arisz Acquisition: +15.11%
  • Intchains ADR: +13.23%
  • Armada Acquisition I: -13.21%
  • XCHG Ltd ADR: -12.27%
  • American Superconductor: +12.48%
  • Emerald Expositions Events Inc: +10.34%
  • COVA Acquisition: -11.19%

For the latest market news and updates, consider following financial news platforms.

This article was generated with AI assistance and has been reviewed by an editor.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker